Nomura Holdings
TEVA icon

Nomura Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Nomura Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-610,900
Closed -$19.1M – 2111
2025
Q4 		$19.1M Buy
610,900
+462,400
+311% +$11.4M 0.03% 330
2025
Q3 		$3M Buy
148,500
+86,000
+138% +$1.51M ﹤0.01% 978
2025
Q2 		$1.05M Buy
+62,500
New +$1.01M ﹤0.01% 986
2025
Q1 		– Sell
-437,500
Closed -$9.64M – 2361
2024
Q4 		$9.64M Buy
+437,500
New +$7.96M 0.01% 519
2023
Q3 		– Sell
-287,000
Closed -$2.16M – 1636
2023
Q2 		$2.16M Buy
+287,000
New +$2.33M 0.01% 702
2023
Q1 		– Sell
-670,000
Closed -$6.11M – 1715
2022
Q4 		$6.11M Hold
670,000
– – 0.03% 435
2022
Q3 		$5.41M Buy
+670,000
New +$5.92M 0.02% 529
2018
Q3 		– Sell
-300,000
Closed -$5.69M – 1500
2018
Q2 		$5.69M Buy
+300,000
New +$6.12M 0.02% 480
2018
Q1 		– Sell
-150,000
Closed -$2.85M – 1670
2017
Q4 		$2.85M Hold
150,000
– – 0.01% 777
2017
Q3 		$2.64M Buy
+150,000
New +$3.38M 0.01% 764
2016
Q4 		– Sell
-318,000
Closed -$14.6M – 1645
2016
Q3 		$14.6M Sell
318,000
-382,000
-55% -$19.9M 0.04% 222
2016
Q2 		$35.2M Buy
+700,000
New +$37.3M 0.11% 96
2015
Q1 		– Sell
-2,125,000
Closed -$107M – 2250
2014
Q4 		$107M Buy
2,125,000
+125,000
+6% +$6.96M 0.29% 52
2014
Q3 		$101M Buy
2,000,000
+1,920,000
+2,400% +$102M 0.27% 67
2014
Q2 		$4.19M Sell
80,000
-64,700
-45% -$3.31M ﹤0.01% 762
2014
Q1 		$7.59M Buy
+144,700
New +$6.69M ﹤0.01% 574

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings's TEVA Position: Q1 2026 in Review

Nomura Holdings opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 2,338,602 shares worth $70.4M. The stake represents 0.19% of the portfolio and ranks #85 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in TEVA as recently as Q3 2025.

Nomura Holdings first reported a position in TEVA in Q2 2013 and has held it in 42 quarters since. The position peaked at $75.9M in Q3 2014. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Nomura Holdings held 2,338,602 shares of Teva Pharmaceuticals worth $70.4M as of Q1 2026.
  • Teva Pharmaceuticals was a new Nomura Holdings position in Q1 2026.
  • Teva Pharmaceuticals made up 0.19% of Nomura Holdings's portfolio in Q1 2026, its #85 holding.
  • Nomura Holdings first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 42 quarters since.
  • Nomura Holdings's Teva Pharmaceuticals position peaked at $75.9M in Q3 2014.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.